u/marta_dziedzic

Agreed that goal weights picked at the start are guesses. Mine was, and I revised it twice.

week 9 is early to draw any conclusion at all

Yes — regional stock is the single biggest variable and it barely gets mentioned outside this board.

Have you had the conversation with a clinician yet?

Adding the one process step — write down where you are before you change anything.

It is a dual GIP and GLP-1 receptor agonist, and the GIP arm is the part that has no equivalent in the semaglutide threads. That is why the side-effect profile reads differently rather than just milder.

What is the waist doing? That is usually the number still moving during a scale stall.

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

Careful — that reads as advice about what someone else should do, and this board is for describing your own.

Had the conversation with a clinician before stopping rather than after. Considerably easier that way round.

write down where you are before you change anything

That is a packaging observation, not a transit observation. Worth posting, worth separating.

a peer-to-peer call is often faster than a written appeal

appeal in writing even when they say a call is enough

week 2 is early to draw any conclusion at all

Withdrawal studies across this class consistently show substantial regain after discontinuation, with appetite typically returning before weight changes. That is a description of the pharmacology of a chronic condition.

Same experience with the appetite effect being flatter across the week rather than front-loaded.

Careful — that reads as advice about what someone else should do, and this board is for describing your own.

How many shipments does your figure cover?

Push back: "gentler than sema" is a population statement. Plenty of people on this board have the opposite experience and they are not doing it wrong.

Push back: comparing a July transit with a February one on the same lane is not a comparison.

employer plans and individual plans are different fights

Same lane, four orders, 5 to 11 days, all four within a couple of days of the quote. That consistency is the actual finding.

2.5 is the starter dose and it is not meant to be the dose that works

the trials titrated on a calendar, real people titrate on symptoms

That percentage is body weight change, not body fat. Different measurement, and the distinction gets lost every time.